These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38184232)

  • 1. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy.
    Zheng B; Chen Y; Niu L; Zhang X; Yang Y; Wang S; Chen W; Cai Z; Huang W; Huang W
    J Control Release; 2024 Feb; 366():596-610. PubMed ID: 38184232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
    Desai NP; Trieu V; Hwang LY; Wu R; Soon-Shiong P; Gradishar WJ
    Anticancer Drugs; 2008 Oct; 19(9):899-909. PubMed ID: 18766004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.
    Pascual-Pasto G; Castillo-Ecija H; Unceta N; Aschero R; Resa-Pares C; Gómez-Caballero A; Vila-Ubach M; Muñoz-Aznar O; Suñol M; Burgueño V; Gomez-Gonzalez S; Sosnik A; Ibarra M; Schaiquevich P; de Álava E; Tirado OM; Mora J; Carcaboso AM
    J Control Release; 2022 Feb; 342():81-92. PubMed ID: 34974029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.
    Duan J; Hao Y; Wan R; Yu S; Bai H; An T; Zhao J; Wang Z; Zhuo M; Wang J
    Thorac Cancer; 2017 May; 8(3):138-146. PubMed ID: 28304139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
    Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
    Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.
    Neesse A; Frese KK; Chan DS; Bapiro TE; Howat WJ; Richards FM; Ellenrieder V; Jodrell DI; Tuveson DA
    Gut; 2014 Jun; 63(6):974-83. PubMed ID: 24067278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism.
    Hoang B; Ernsting MJ; Roy A; Murakami M; Undzys E; Li SD
    Biomaterials; 2015 Aug; 59():66-76. PubMed ID: 25956852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
    Kouchakzadeh H; Safavi MS; Shojaosadati SA
    Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
    Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
    ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biguanide-anchored albumin-based nanoplatform inhibits epithelial-mesenchymal transition and reduces the stemness phenotype for metastatic cancer therapy.
    Jiang T; Wang J; Xie L; Zhou S; Huang Y; Chen Y; Gao X; Xiao W; Chen J
    Acta Biomater; 2023 Nov; 171():565-579. PubMed ID: 37716479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy.
    Zhang Y; Guo Z; Cao Z; Zhou W; Zhang Y; Chen Q; Lu Y; Chen X; Guo Q; Li C; Liang D; Sun T; Jiang C
    Biomaterials; 2018 Nov; 183():243-257. PubMed ID: 30179775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of abraxane on osteosarcoma xenografts in nude mice and expression of secreted protein, acidic and rich in cysteine.
    Yang Y; Niu X; Zhang Q; Hao L; Ding Y; Xu H
    Am J Med Sci; 2012 Sep; 344(3):199-205. PubMed ID: 22222334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A near infrared light-triggered human serum albumin drug delivery system with coordination bonding of indocyanine green and cisplatin for targeting photochemistry therapy against oral squamous cell cancer.
    Wang Y; Xie D; Pan J; Xia C; Fan L; Pu Y; Zhang Q; Ni YH; Wang J; Hu Q
    Biomater Sci; 2019 Dec; 7(12):5270-5282. PubMed ID: 31603446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer Xenografts.
    Kim H; Samuel S; Lopez-Casas P; Grizzle W; Hidalgo M; Kovar J; Oelschlager D; Zinn K; Warram J; Buchsbaum D
    Mol Cancer Ther; 2016 Apr; 15(4):680-8. PubMed ID: 26832793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the relationship between secreted protein acidic and rich in cysteine expression level and therapeutic efficacy of nab-paclitaxel: a meta-analysis.
    Zhou X; Zhang L; Qierang C; Huang M; Yang X; Li L; Jiang J
    Transl Cancer Res; 2021 Feb; 10(2):876-885. PubMed ID: 35116417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
    Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
    Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
    Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
    Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-bound paclitaxel: a next-generation taxane.
    Gradishar WJ
    Expert Opin Pharmacother; 2006 Jun; 7(8):1041-53. PubMed ID: 16722814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.